Bingfeng L. Liu

Shenzhen Key Laboratory For Systems Medicine In Inflammatory Diseases
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation.

The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation.

Journal: Journal of virology

Published: December 03, 2025

History, current status and future of the treatment for irreducible atlantoaxial dislocation

History, current status and future of the treatment for irreducible atlantoaxial dislocation

Journal: Zhonghua yi xue za zhi

Published: November 19, 2025

A self-assembling ferritin nanoparticle-based trivalent vaccine of gB/gE/gH elicits potent immune responses against varicella-zoster virus.

A self-assembling ferritin nanoparticle-based trivalent vaccine of gB/gE/gH elicits potent immune responses against varicella-zoster virus.

Journal: International journal of biological macromolecules

Published: June 12, 2025

The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation.

The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation.

Journal: PLoS biology

Published: May 30, 2025

Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation.

Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation.

Journal: Journal of virology

Published: December 18, 2024

Development of an Assay Evaluating the Inducible HIV-1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA.

Development of an Assay Evaluating the Inducible HIV-1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA.

Journal: Journal of medical virology

Published: October 14, 2024

ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency.

ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency.

Journal: Journal of virology

Published: July 31, 2024

Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.

Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.

Journal: Journal of translational medicine

Published: December 19, 2023

The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments.

The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments.

Journal: Molecular cancer

Published: October 27, 2023

BRD7 as key factor in PBAF complex assembly and CD8+ T cell differentiation.

BRD7 as key factor in PBAF complex assembly and CD8+ T cell differentiation.

Journal: JCI insight

Published: April 19, 2023

The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.

The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.

Journal: Nature immunology

Published: April 17, 2023

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment.

Journal: Molecular therapy oncolytics

Published: March 21, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026